Search results
Results from the WOW.Com Content Network
The Enabling Act of 1933 (German: Ermächtigungsgesetz), officially titled Gesetz zur Behebung der Not von Volk und Reich (lit. ' Law to Remedy the Distress of People and Reich ' ), [ 1 ] was a law that gave the German Cabinet – most importantly, the Chancellor – the power to make and enforce laws without the involvement of the Reichstag or ...
The enabling act on 24 February 1923, originally limited until 1 June but extended until 31 October, empowered the cabinet to resist the occupation of the Ruhr. [3] There was an enabling act on 13 October 1923 and an enabling act on 8 December 1923 that would last until the dissolution of the Reichstag on 13 March 1924. [4]
Mometasone, also known as mometasone furoate, is a steroid (specifically, a glucocorticoid) medication used to treat certain skin conditions, hay fever, and asthma. [ 10 ] [ 11 ] [ 12 ] Specifically it is used to prevent rather than treat asthma attacks. [ 10 ]
For treating atopic dermatitis, newer (second generation) corticosteroids, such as fluticasone propionate and mometasone furoate, are more effective and safer than older ones. They are also generally safe and do not cause skin thinning when used intermittently to treat atopic dermatitis flare-ups.
This speech marked Hitler's second appearance before the Reichstag after the Day of Potsdam and led to a parliamentary vote that, for an initial period of four years, suspended the separation of powers outlined in the Weimar Constitution, effectively abolishing democracy in Germany. [1] The Enabling Act came into effect one day later. [1]
Enabling Act (United States) Add languages. Add links. Article; Talk; English. Read; Edit; ... Text is available under the Creative Commons Attribution-ShareAlike 4.0 ...
The methasones (or metasones) are a class of corticosteroids [1] which are generally used in dermatology.They are defined by substitution with a methyl group at the C16α or C16β position of the pregnane steroid nucleus.
It is the first asthma triple-combination therapy; it consists of a fixed-dose combination of three active substances (indacaterol, glycopyrronium bromide and mometasone furoate) in capsules, to be administered using an inhaler. [11] An optional electronic sensor may also be co-packed with the product. [11]